Valve Calcium and Long-Term Health After Valve Replacement for Aortic Stenosis
Studies valve calcium in people having valve replacement for aortic stenosis.
Key facts
- Who runs it
- Eunpyeong St. Mary's Hospital
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- Impact of Aortic Annulus Calcification on Long-Term Outcomes Following Transcatheter Aortic Valve Replacement: SAINT-TAVR Calcium Registry
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 2 Oct 2024
- Expected to end
- 2 Oct 2034
- Type of study
- Observational
- Treatments tested
- Transcatheter aortic valve replacement with ballon-expandable or self-expandable valves
- Record updated
- 9 December 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have had TAVR (a heart valve replaced through a tube in a blood vessel) for severe aortic stenosis. It studies how calcium in the valve ring affects health over 3 years.
- Age
- 19 years or older
- Sex
- All
- Disease stage
- Severe aortic stenosis (narrowing of the main heart valve)
- Earlier treatment
- Must have had transcatheter aortic valve replacement (TAVR) as part of regular care.
Main reasons for not taking part
- People who have not given written informed consent for this study cannot join.
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Adults aged 19 years or older
- Patients who have undergone transcatheter aortic valve replacement (TAVR) for severe aortic stenosis
- Individuals who have voluntarily provided written informed consent to participate
Who cannot take part
- Individuals who have not provided written informed consent for this study
Where in South Korea
- Division of Cardiology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of KoreaSeoul, South KoreaContact: Hye-Yeon Seo, A Master´s degreeTaking people
About the trial
What the trial wants to find out
The goal of this observational study is to learn about the long-term effects of aortic valve annular calcification in patients undergoing transcatheter aortic valve replacement (TAVR). The main question it aims to answer is:
Read full original descriptionShow less
Does the degree of aortic valve annular calcification prior to TAVR influence long-term clinical outcomes, including major adverse cardiovascular events including all-cause mortality, over a 3-year period?
Participants who have undergone TAVR as part of their regular medical care for severe aortic stenosis will have their pre-procedural imaging and clinical outcomes evaluated for a 3-year follow-up period.
Treatments tested
- Transcatheter aortic valve replacement with ballon-expandable or self-expandable valves
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Aortic Annulus Calcification on Long-Term Outcomes Following Transcatheter Aortic Valve Replacement: Scientific Association of Interventional Cardiology - Transcatheter Aortic Valve Replacement (SAINT-TAVR) Calcium Registry
- Plain-language title
- Valve Calcium and Long-Term Health After Valve Replacement for Aortic StenosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 9 December 2024